Sales and profits fall at Fischer

Article

Fischer Imaging chief executive Morgan Nields blamed "a radical restructuring"of theU.S. imaging equipment market for sales and profit declines in1994 for the Denver-based general radiography equipment manufacturer. Revenue for the year

Fischer Imaging chief executive Morgan Nields blamed "a radical restructuring"of theU.S. imaging equipment market for sales and profit declines in1994 for the Denver-based general radiography equipment manufacturer.

Revenue for the year ending Dec. 31, 1994, was $68.4 million,compared to $73.3 million in 1993. The company lost $5.6 millionin 1994 after reporting a break-even performance for the previousyear.

Fourth-quarter trends were also down. As revenue fell 5.6%to $18.3 million, Fischer posted a fourth-quarter loss of $980,000,compared to a profit of $462,000 for the same period of 1993.The downturn was attributed principally to delays in anticipatedoriginal equipment manufacturer shipments, caused by customer-requesteddesign changes in 1994, according to the company.

Nields linked Fischer's performance last year with an estimated30% revenue decline in $1 billion domestic diagnostic x-ray equipmentmarket in 1994.

"We believe the market is undergoing a continuing radicalrestructuring as providers and payors realign strategies in acompetitive marketplace," he said.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.